Eli Lilly bagged $5bn as demand for supply ran hot on a jam-packed Monday
US drugmaker's multi-tranche deal kicked off a week heavily front-loaded with deals
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ 4 capital markets databases
- ✔ Daily newsletters across markets and asset classes
- ✔ 2 weekly podcasts